ADVAPOINT Trademark

Trademark Overview

On Tuesday, November 24, 2020, a trademark application was filed for ADVAPOINT with the United States Patent and Trademark Office. The USPTO has given the ADVAPOINT trademark a serial number of 90340929. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, July 23, 2024. This trademark is owned by BluePoint Intellectual Property, LLC. The ADVAPOINT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in treating human diseases, namely, the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of oncologic conditions; drug products for oncology related conditions, namely, drugs in finished dosage form; anti-cancer agents; injectable anti-cancer agents; injectable medicines for use in oncology; antiemetic preparations
advapoint

General Information

Serial Number90340929
Word MarkADVAPOINT
Filing DateTuesday, November 24, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 18, 2022

Trademark Statements

Description of MarkThe mark consists of the literal element "AdvaPoint" partially overlaid on a circular shape formed with curved lines of dots of various sizes.
Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in treating human diseases, namely, the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of oncologic conditions; drug products for oncology related conditions, namely, drugs in finished dosage form; anti-cancer agents; injectable anti-cancer agents; injectable medicines for use in oncology; antiemetic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBluePoint Intellectual Property, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressConshohocken, PA 19428
Party NameBluePoint Intellectual Property, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressConshohocken, PA 19428

Trademark Events

Event DateEvent Description
Friday, November 27, 2020NEW APPLICATION ENTERED
Saturday, January 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 7, 2021ASSIGNED TO EXAMINER
Wednesday, May 12, 2021NON-FINAL ACTION WRITTEN
Tuesday, February 2, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 3, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 3, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 12, 2021NON-FINAL ACTION E-MAILED
Wednesday, May 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 3, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 14, 2022SOU TEAS EXTENSION RECEIVED
Saturday, July 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 14, 2022SOU EXTENSION 1 FILED
Thursday, July 14, 2022SOU EXTENSION 1 GRANTED
Thursday, January 25, 2024SOU EXTENSION 4 FILED
Wednesday, January 25, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 25, 2023SOU EXTENSION 2 FILED
Wednesday, January 25, 2023SOU EXTENSION 2 GRANTED
Friday, January 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 17, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 17, 2023SOU EXTENSION 3 FILED
Thursday, August 17, 2023SOU EXTENSION 3 GRANTED
Saturday, August 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 25, 2024SOU EXTENSION 4 GRANTED
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 5 FILED
Tuesday, July 23, 2024SOU EXTENSION 5 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

advapoint preparations pharmaceutical diseases treatment agents oncology cancer conditions anti namely